Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
<p>Abstract</p> <p>Background</p> <p>Using non-steroidal anti-inflammatory drugs (NSAIDs) as a case, we used Taiwan's National Health Insurance (NHI) database, to empirically explore the association between policy interventions (price regulation, new drug entry, an...
Main Authors: | Tsai Yi-Wen, Hsiao Fei-Yuan, Huang Weng-Foung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/10/218 |
Similar Items
-
Price Regulation, New Entry, and Information Shock on Pharmaceutical Market
by: Fei-Yuan Hsiao, et al.
Published: (2007) -
A Nationwide Survey of Risk Factors for Stillbirth in Taiwan, 2001–2004
by: I-Jan Hu, et al.
Published: (2012-04-01) -
Essays on entry and market profitability in the UK pharmaceuticals
by: Yan, Weijie
Published: (2019) -
Entry and Competition in the Pharmaceutical Market following Patent Expiry
by: Appelt, Silvia
Published: (2011) -
Market Entry Modeling for Biotech Pharmaceutical Firms to China
by: Finie Winata, et al.
Published: (2011)